Is AstraZeneca’s adenovirus technology behind the blood clots?

Dr Kylie Quinn (PhD)

This week, US health authorities recommended pausing the rollout of the one-shot Johnson & Johnson/Janssen COVID-19 vaccine while investigations into exceptionally rare blood clots take place.

Six women suffered blood clots out of nearly seven million doses administered.